Since March is National Kidney Month and March 11, 2010 is officially World Kidney Day, we'd like to acknowledge the tremendous success of our UCSF Transplantation Program. UCSF has performed more kidney transplants than any other institution in the world — more than 8,300 since 1964 — and is the fifth largest center for living-donor kidney transplants in the country.
Each year, the transplant team evaluates about 1,200 patients and performs more than 350 kidney transplants. Our one-year success rate is one of the highest in Northern California and our pediatric kidney transplant program is one of the largest of its kind in the U.S. Additionally, we are also a leader in pancreas and pancreas-kidney transplants for patients with diabetes. Currently we offer three kinds of pancreas transplants: a combined pancreas and kidney transplant for diabetics suffering from end-stage kidney disease (ESRD); a solitary pancreas transplant to prevent the onset of diabetic complications in the kidney, including a previously transplanted kidney; and an islet transplant — to effectively restore insulin independence in patients with diabetes. Since islet transplantation is still considered clinical research, we encourage you to learn about our clinical trials sponsored by the CIT Consortium, an international collaborative effort that is examining outcomes of islet transplantation in type 1 diabetes and evaluating novel immunosuppressive agents in preventing islet rejection. We are also in the process of launching our islet-after-kidney trial. For more information, contact [email protected]